Substantia innominata: MR findings in Parkinson’s disease

被引:0
|
作者
Hirobumi Oikawa
Makoto Sasaki
Shigeru Ehara
Takashi Abe
机构
[1] Iwate Medical University,High Field Magnetic Resonance Imaging Research Institute
[2] Iwate Medical University,Department of Neurology
[3] Iwate Medical University,undefined
来源
Neuroradiology | 2004年 / 46卷
关键词
Substantia innominata; Parkinson’s disease; Mini-mental-status examination; Nucleus basalis of Meynert;
D O I
暂无
中图分类号
学科分类号
摘要
To elucidate MR imaging changes of the substantia innominata in Parkinson’s disease (PD), using a 1.5-T superconductive MR unit, the thickness of the substantia innominata was measured on coronal thin-section images in 44 PD patients and 20 age-matched control subjects. We also evaluated the correlation between the thickness of the substantia innominata and mental status in PD patients. Mean thickness of the substantia innominata was 2.3 mm in PD patients, and 2.5 mm in control subjects. Thinning of the substantia innominata was statistically significant in PD patients compared with control subjects, although there were large overlaps. Among the PD patients, thinning was remarkable in cases with dementia. A positive correlation between thickness of substantia innominata and score of Mini-Mental-Status-Examination was also observed in PD patients. Atrophy of the substantia innominata was demonstrated, especially in PD patients with cognitive impairment, on coronal MR images, and this is compatible with the previous pathological reports.
引用
收藏
页码:817 / 821
页数:4
相关论文
共 50 条
  • [21] KINDLING OF THE SUBSTANTIA INNOMINATA IN RATS
    HOSHINO, S
    KUMASHIRO, H
    MORI, N
    EPILEPSIA, 1986, 27 (05) : 601 - 601
  • [22] Ultrasonography of the substantia nigra in Parkinson's disease
    Ressner, P.
    Skoloudik, D.
    Kanovsky, P.
    MOVEMENT DISORDERS, 2006, 21 : S615 - S615
  • [23] Substantia nigra hyperechogenicity in Parkinson's disease
    Bor-Seng-Shu, Edson
    Fonoff, Erich Talamoni
    Barbosa, Egberto Reis
    Teixeira, Manoel Jacobsen
    ACTA NEUROCHIRURGICA, 2010, 152 (12) : 2085 - 2087
  • [24] Hyperechogenicity of the substantia nigra in Parkinson's disease
    Ressner, P
    Skoloudik, D
    Kanovsky, P
    NEUROLOGY, 2006, 66 (05) : A114 - A114
  • [25] Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease
    Hanyu, H
    Tanaka, Y
    Sakurai, H
    Takasaki, M
    Abe, K
    NEUROSCIENCE LETTERS, 2002, 319 (01) : 33 - 36
  • [26] Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease?
    Gao, Fu-qiang
    Pettersen, Jacqueline A.
    Bocti, Christian
    Nestor, Sean M.
    Kiss, Alex
    Black, Sandra E.
    NEUROBIOLOGY OF AGING, 2013, 34 (07) : 1807 - 1814
  • [27] Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease
    Reimao, Sofia
    Lobo, Patricia Pita
    Neutel, Dulce
    Guedes, Leonor Correia
    Coelho, Miguel
    Rosa, Mario M.
    Azevedo, Pedro
    Ferreira, Joana
    Abreu, Daisy
    Goncalves, Nilza
    Nunes, Rita G.
    Campos, Jorge
    Ferreira, Joaquim J.
    MOVEMENT DISORDERS, 2015, 30 (07) : 953 - 959
  • [28] Comparison of proton-MR-spectroscopy of the substantia nigra in patients with Parkinson's disease, relatives and controls
    Di Santo, A.
    Klose, U.
    Schweitzer, K.
    Godau, J.
    Berg, D.
    MOVEMENT DISORDERS, 2007, 22 : S233 - S233
  • [29] Reduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease
    Jaswal, Gurpreet
    Swardfager, Walter
    Gao, Fu-qiang
    Nestor, Sean M.
    Ganda, Anoop
    Cogo-Moreira, Hugo
    Sahlas, Demetrios J.
    Stuss, Donald T.
    Moody, Alan
    Black, Sandra E.
    NEUROBIOLOGY OF AGING, 2018, 66 : 23 - 31
  • [30] Organochlorine insecticides in substantia nigra in Parkinson's disease
    Corrigan, FM
    Wienburg, CL
    Shore, RF
    Daniel, SE
    Mann, D
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 2000, 59 (04): : 229 - 234